A blog maintained by an investor in Immune Response Corporation now called Orchestra Therapeutics, Inc. (OCHTQ.PK). Immune Response BioPharma claims to now own the research and trial results from Immune Response and is attempting to market their findings through the Immune Response BioPharma name.
Thursday, June 30, 2011
Immune Response BioPharma
The people at Immune Response BioPharma have sent a letter to the FDA trying to get approval of the Remune vaccine developed by Immune Response aka Orchestra. In the letter they refer to the people at Immune Response by saying, "while the former management was unethical and irresponsible and cared only about their wallets and stock price." This is a true statement. Thousands of honest investors lost all their money due to the false statements and research conducted by Kevin Kimberlin's and Spencer Trask's company. My question is why would the FDA approve anything based on the research results provided by people who were "unethical and irresponsible." I mean lying to investors and trying to manipulate lap test results were what Immune Response was known for. The FDA and future investors would be fools to trust any of the Immune Response's research data. If they believe in the science they are going to have to start from scratch and repeat everything with reputable scientists and doctors administering the clinical trials and then allow for independent peer review from their fellow professionals in the field.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment